Liver-Targeted Nanoparticles Facilitate the Bioavailability and Anti-HBV Efficacy of Baicalin In Vitro and In Vivo

The anti-hepatitis B virus (HBV) efficacy of baicalin (BA) is mediated by HBV-related hepatocyte nuclear factors (HNFs). However, this efficacy is severely limited by the low bioavailability of BA. Therefore, a novel liver-targeted BA liposome was constructed to promote the bioavailability and antiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Weiming, Niu, Yijun, Ai, Xin, Xia, Chengjie, Geng, Ping, Zhu, Haiyan, Zhou, Wei, Huang, Hai, Shi, Xunlong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025464/
https://www.ncbi.nlm.nih.gov/pubmed/35453650
http://dx.doi.org/10.3390/biomedicines10040900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025464/
https://www.ncbi.nlm.nih.gov/pubmed/35453650
http://dx.doi.org/10.3390/biomedicines10040900

Ejemplares similares